BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19099930)

  • 1. [Association between lysosomal cysteine protease cathepsin's activation and left ventricular function and remodeling in hypertensive heart failure rats].
    Cheng XW; Zhang J; Song H; Yang G; Qin XZ; Guan LK; Jin H; Okumura K; Murohara T
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):51-6. PubMed ID: 19099930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure.
    Cheng XW; Obata K; Kuzuya M; Izawa H; Nakamura K; Asai E; Nagasaka T; Saka M; Kimata T; Noda A; Nagata K; Jin H; Shi GP; Iguchi A; Murohara T; Yokota M
    Hypertension; 2006 Nov; 48(5):979-87. PubMed ID: 16982960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S; Kobayashi N; Yagi H; Mori Y; Matsuoka H
    J Cardiovasc Pharmacol; 2006 May; 47(5):629-35. PubMed ID: 16775500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats.
    Suzuki T; Akasaka Y; Namiki A; Ito K; Ishikawa Y; Yamazaki J; Ishii T
    J Hypertens; 2008 Dec; 26(12):2436-44. PubMed ID: 19008723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor.
    Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Hori M; Miwa T; Masuyama T
    Circulation; 2004 May; 109(17):2143-9. PubMed ID: 15051632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
    Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
    Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Nishizawa T; Noda A; Izawa H; Nagata K; Murohara T; Yokota M
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):770-9. PubMed ID: 16810078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.
    Cheng XW; Murohara T; Kuzuya M; Izawa H; Sasaki T; Obata K; Nagata K; Nishizawa T; Kobayashi M; Yamada T; Kim W; Sato K; Shi GP; Okumura K; Yokota M
    Am J Pathol; 2008 Aug; 173(2):358-69. PubMed ID: 18583318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of high thoracic epidural anesthesia on ventricular remodeling and expression of beta(3)-adrenoceptor in rats with heart failure induced by acute myocardial infarction].
    Chen GZ; Wang QX; Wu XZ; Liu R; Jiang HQ
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3366-70. PubMed ID: 20193570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
    Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats.
    Ikeda S; Hamada M; Qu P; Hiasa G; Hashida H; Shigematsu Y; Hiwada K
    Clin Sci (Lond); 2002 Mar; 102(3):329-35. PubMed ID: 11869174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial left ventricular unloading reverses contractile dysfunction and helps recover gene expressions in failing rat hearts.
    Wang J; Marui A; Ikeda T; Komeda M
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):27-31. PubMed ID: 18006556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats.
    Nonaka-Sarukawa M; Okada T; Ito T; Yamamoto K; Yoshioka T; Nomoto T; Hojo Y; Shimpo M; Urabe M; Mizukami H; Kume A; Ikeda U; Shimada K; Ozawa K
    J Gene Med; 2008 Apr; 10(4):368-74. PubMed ID: 18205252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.
    Liang Q; Elson AC; Gerdes AM
    J Card Fail; 2006 Aug; 12(6):479-86. PubMed ID: 16911916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of activin A in heart failure: potential role in myocardial remodeling.
    Yndestad A; Ueland T; Øie E; Florholmen G; Halvorsen B; Attramadal H; Simonsen S; Frøland SS; Gullestad L; Christensen G; Damås JK; Aukrust P
    Circulation; 2004 Mar; 109(11):1379-85. PubMed ID: 14993131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.
    dos Santos L; Salles TA; Arruda-Junior DF; Campos LC; Pereira AC; Barreto AL; Antonio EL; Mansur AJ; Tucci PJ; Krieger JE; Girardi AC
    Circ Heart Fail; 2013 Sep; 6(5):1029-38. PubMed ID: 23894014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of beta3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure].
    Gan RT; Li WM; Wang X; Wu S; Kong YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):675-8. PubMed ID: 17996136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.